Overview

Antiviral Activity of AZD7295 in HCV Carriers

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
PK, safety study of AZD7295 in HCV carriers
Phase:
Phase 1
Details
Lead Sponsor:
Arrow Therapeutics
Treatments:
Antiviral Agents